Related Experiment Video

Updated: Apr 14, 2026

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

2.5K

Interleukin-11: A pivotal player and potential therapeutic target in prostate cancer

Jinghua Zhong1,2,3,4, Xiaolu Duan1,2,3,4, Ziyi Wei5

  • 1Department of Urology, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.

Current Urology
|April 13, 2026
PubMed

Keywords:
Bone metastasisChemotherapeutic resistanceDiagnosisInterleukin-11Prostate cancerTarget therapy

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K
An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

36.2K

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.5K